Point72 Asset Management’s Assembly Biosciences ASMB Stock Holding History

Point72 Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.55M	Sell	344,105 -256,504	-43%	-$7.32M	0.01%	1288
2025 Q4	$20.4M	Buy	600,609 +304,592	+103%	+$9.81M	0.02%	873
2025 Q3	$7.58M	Buy	+296,017	New	+$6.49M	0.01%	910
2019 Q2	–	Sell	-8,333	Closed	-$1.97M	–	1328
2019 Q1	$1.97M	Buy	+8,333	New	+$2.11M	0.01%	702
2018 Q4	–	Sell	-913	Closed	-$407K	–	956
2018 Q3	$407K	Buy	+913	New	+$428K	﹤0.01%	939

Other funds holding ASMB

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management's ASMB Position: Q1 2026 in Review

Point72 Asset Management reduced its Assembly Biosciences (ASMB) stake by 43% in Q1 2026, selling an estimated $7.32M and leaving 344,105 shares worth $9.55M. The position accounts for 0.01% of the portfolio, ranked #1288.

Point72 Asset Management first reported a position in ASMB in Q3 2018 and has held it in 5 quarters since. The position peaked at $20.4M in Q4 2025. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

Point72 Asset Management held 344,105 shares of Assembly Biosciences worth $9.55M as of Q1 2026.
Point72 Asset Management sold 256,504 Assembly Biosciences shares in Q1 2026, an estimated $7.32M.
Assembly Biosciences made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1288 holding.
Point72 Asset Management first reported a position in Assembly Biosciences in Q3 2018 and has held it in 5 quarters since.
Point72 Asset Management's Assembly Biosciences position peaked at $20.4M in Q4 2025.
75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.